What is AARD's cash & equivalents?

AARD (AARD) reported cash & equivalents of $62.44M in Q1 2026.

How has AARD's cash & equivalents changed year-over-year?

AARD's cash & equivalents increased by 135.6% year-over-year, from $26.5M to $62.44M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

AARD AARD Cash & Equivalents

Cash & Equivalents at other companies

AbbVieABBV

$9.39B+81.5%

Relmada Therapeutics, Inc.RLMD

$9.78M+750%

Rhythm Pharmaceuticals, Inc.RYTM

$62.14M-41.4%

Aquestive Therapeutics, Inc.AQST

$110.73M+61.3%

Viking TherapeuticsVKTX

$118.12M+211%

ArvinasARVN

$87.3M+7.8%

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's cash & equivalents?: AARD (AARD) reported cash & equivalents of $62.44M in Q1 2026.
How has AARD's cash & equivalents changed year-over-year?: AARD's cash & equivalents increased by 135.6% year-over-year, from $26.5M to $62.44M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.